D ecisions imply choices between options, leading to a need for comparative information. Those decisions interesting enough to research tend not to be straightforward. This situation occurs frequently when the idiosyncrasies of the human body meet the creativity of medical science and the many new technologies developed annually. Patients often find their medical choices daunting and experience frustration when information is insufficient or not tailored to their particular situation. The United States has committed to comparative effectiveness research (CER) investments that are expected to pay off in terms of increasing the knowledge base about relevant choices, including 100 real health care dilemmas recently prioritized by the Institute of Medicine (available at www.iom.edu/ cerpriorities).
The paradigm, as well as the product, of comparative research puts decision makers in the driver seat, with an information highway worth the journey. Patients, clinicians, health care organizations, technology inventors, governments, and insurers can travel on the same highway and make much more informed decisions based on their respective preferences and needs.
As a research and education community, the Society for Medical Decision Making's decision choices tend toward the methodological-is one research technique more robust than another for a specific CER question? But our community is also interested in thinking about how to increase the likelihood of realizing the potential benefits of CER.
These essays tackle both of these themes in an accessible manner. We hope that the set together fascinates you as much as it did us, as research practitioners of CER. All of us are also patients at one point or another. We hope you wear your patient hat in any discussion of CER and anticipate that these essays will enlighten those conversations.
Adrian Levy, Brian Harrigan, Karissa Johnston, and Andrew Briggs ask the following: will CER meet the objectives purported of improving health care decision making, changing clinical practice, promoting increased value, and reducing disparities? David Howard explores cancer screening decision making in Europe and the United States to consider similar questions.
Dan Jonas and Karen Crotty cover the timely and important topic of workforce training in CER, focusing mostly on systematic reviews and technology assessment approaches used within the US-based Evidence-based Practice Center program supported by the Agency for Healthcare Research and Quality.
Michael Kattan writes a compelling piece about a decision aid that could help communicate patientspecific harms and benefits for medical decisions about diagnostic tests or treatment options. This approach gets to the heart of CER's potential use in patient-physician communication.
Anirban Basu extends this personalized medicine ambition for CER to the research enterprise and suggests that available data and new scientific methods might be used to generate individual estimates for a given patient's decision about medical options. It's a tall order for science but one worth striving for. Basu argues that ''i-CER'' (individualized CER) could solve some of the US health reform policy dilemmas posed by Levy et al. and Howard.
The final winning essay in the set is by Nancy Neil and offers a succinct reflection on the interesting interplays between CER, decision analysis models, real-world needs, and the theme of transparency. It is a worthwhile conversation to start and refreshing to see it started with the goals for modeling a decision maker's problem, instead of the types of modeling methods in the decision sciences tool box.
We are incredibly fortunate to have received a number of interesting submissions and be able to share some of the best with Medical Decision Making readers. Congratulations to the finalists, and many thanks to all of those who offered their pieces to this contest. 
